Snap-on Form 4: CEO Option Exercise and 10b5-1 Sales Reduce Holdings
Rhea-AI Filing Summary
Nicholas T. Pinchuk, Chairman, President and CEO of Snap-on Incorporated (SNA), reported option exercise and multiple open-market sales on 08/11/2025. He exercised stock options with an $138.03 exercise price to effect an acquisition of 33,750 shares, and pursuant to a Rule 10b5-1 plan (adopted October 24, 2024) sold a total of 23,042 shares in four transactions. The sales were executed at weighted-average prices of $320.1701, $320.969, $321.8626 and $322.618. Following these transactions, the filing shows Mr. Pinchuk directly beneficially owns 815,219.2893 shares, with an additional 858.5538 shares indirectly via a 401(k) plan and various outstanding options, restricted stock units, performance units and deferred stock units documented in the filing.
Positive
- None.
Negative
- None.
Insights
TL;DR Routine option exercise with planned sales under a 10b5-1 plan; sizable proceeds but beneficial ownership remains substantial.
The filing documents an exercise of 33,750 options at $138.03 and coordinated sales of 23,042 shares via a pre-established Rule 10b5-1 plan. Sales occurred at weighted-average prices between $320.17 and $322.62, implying multi-million dollar gross proceeds. This is a typical liquidity event for executives exercising vested options; it does not indicate an unusual one-off disclosure such as accelerated insider divestiture. The reporting also shows continued large holdings and multiple long-dated option grants and equity awards, which retain management alignment with shareholders.
TL;DR Transactions executed under a documented 10b5-1 plan and include option exercise plus pre-planned sales; disclosure follows expected SEC Form 4 practices.
The Form 4 states the transactions were carried out pursuant to a Rule 10b5-1 trading plan adopted on October 24, 2024, and notes the option exercised was fully vested. The filing provides weighted-average sale prices and commits to furnish trade-level details on request. From a governance perspective, use of a 10b5-1 plan and clear explanatory footnotes are appropriate controls for insider trading compliance and reduce ambiguity about intent behind sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 33,750 | $0.00 | -- |
| Exercise | Common Stock | 33,750 | $138.03 | $4.66M |
| Sale | Common Stock | 5,209 | $320.1701 | $1.67M |
| Sale | Common Stock | 15,585 | $320.969 | $5.00M |
| Sale | Common Stock | 2,025 | $321.8626 | $652K |
| Sale | Common Stock | 223 | $322.618 | $72K |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Performance Units | -- | -- | -- |
| holding | Performance Units | -- | -- | -- |
| holding | Performance Units | -- | -- | -- |
| holding | Deferred Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024. Includes 1.5215 shares acquired under a dividend reinvestment plan. This transaction was executed in multiple trades at prices ranging from $319.49 to $320.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $320.49 to $321.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $321.49 to $322.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This transaction was executed in multiple trades at prices ranging from $322.50 to $322.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. This information is based on a plan statement dated June 30, 2025. Option fully vested. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024. Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column. 1 for 1. The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment. If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits. Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.
